Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CSGALNACT2 |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → CSGALNACT2 |
| (<<) ADRBK1 → CSGALNACT2 |
| (<<) CCDC108 → CSGALNACT2 |
| (<<) CEP170 → CSGALNACT2 |
| (<<) CYP1A2 → CSGALNACT2 |
| (<<) EIF6 → CSGALNACT2 |
| (<<) ITGAV → CSGALNACT2 |
| (<<) LOC92659 → CSGALNACT2 |
| (<<) LRP5 → CSGALNACT2 |
| (<<) PLCH2 → CSGALNACT2 |
| (<<) RB1 → CSGALNACT2 |
| (<<) RCBTB1 → CSGALNACT2 |
| (<<) RNF11 → CSGALNACT2 |
| (<<) SULF1 → CSGALNACT2 |
| (<<) SYNGR4 → CSGALNACT2 |
| (<<) T → CSGALNACT2 |
| (<<) THRA → CSGALNACT2 |
| (<<) UBE2D1 → CSGALNACT2 |
| Downstream (Children) |
|---|
| CSGALNACT2 → ABLIM1 (>>) |
| CSGALNACT2 → ATIC (>>) |
| CSGALNACT2 → ATP2B4 (>>) |
| CSGALNACT2 → ATP2C1 (>>) |
| CSGALNACT2 → CALM3 (>>) |
| CSGALNACT2 → CDC42 (>>) |
| CSGALNACT2 → DEAF1 (>>) |
| CSGALNACT2 → EP300 (>>) |
| CSGALNACT2 → ERBB3 (>>) |
| CSGALNACT2 → GALK1 (>>) |
| CSGALNACT2 → GLS (>>) |
| CSGALNACT2 → GLTPD1 (>>) |
| CSGALNACT2 → GNG10 (>>) |
| CSGALNACT2 → GPNMB (>>) |
| CSGALNACT2 → GRHPR (>>) |
| CSGALNACT2 → HIF1A (>>) |
| CSGALNACT2 → HIST1H3J (>>) |
| CSGALNACT2 → IL1B (>>) |
| CSGALNACT2 → KLF10 (>>) |
| CSGALNACT2 → KRT75 (>>) |
| CSGALNACT2 → MAP3K1 (>>) |
| CSGALNACT2 → MAPK8 (>>) |
| CSGALNACT2 → MT3 (>>) |
| CSGALNACT2 → NFKBIB (>>) |
| CSGALNACT2 → PRSS22 (>>) |
| CSGALNACT2 → RAF1 (>>) |
| CSGALNACT2 → RBL2 (>>) |
| CSGALNACT2 → RGS20 (>>) |
| CSGALNACT2 → RHOQ (>>) |
| CSGALNACT2 → RRP9 (>>) |
| CSGALNACT2 → SGMS2 (>>) |
| CSGALNACT2 → SMAD1 (>>) |
| CSGALNACT2 → TGFB2 (>>) |
| CSGALNACT2 → WNT6 (>>) |
| CSGALNACT2 → YWHAQ (>>) |
| CSGALNACT2 → ZNF215 (>>) |
